Role of splenomegaly
| . | With splenomegaly, no. patients . | No splenomegaly, no. patients . | P for positive association with splenomegaly . |
|---|---|---|---|
| Cytopenias alone | 21 | 12 | < .001 |
| Hepatomegaly | 22 | 7 | < .001 |
| Granuloma | 17 | 11 | < .001 |
| Enteropathy | 14 | 15 | .03 |
| Bronchiectasis | 33 | 51 | .04 |
| Cytopenias + solid organ autoimmunity | 4 | 3 | .2 |
| Solid organ–specific autoimmunity alone | 28 | 65 | 1.0 |
| Total | 100 | 234 |
| . | With splenomegaly, no. patients . | No splenomegaly, no. patients . | P for positive association with splenomegaly . |
|---|---|---|---|
| Cytopenias alone | 21 | 12 | < .001 |
| Hepatomegaly | 22 | 7 | < .001 |
| Granuloma | 17 | 11 | < .001 |
| Enteropathy | 14 | 15 | .03 |
| Bronchiectasis | 33 | 51 | .04 |
| Cytopenias + solid organ autoimmunity | 4 | 3 | .2 |
| Solid organ–specific autoimmunity alone | 28 | 65 | 1.0 |
| Total | 100 | 234 |
Numbers and types of complications in patients with and without splenomegaly and the level of significance for each.